Utility of IL-28B Polymorphisms in the Era of Direct-Acting Antiviral Therapy

Схожие документы

• Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B
  по: Dahari, Harel, et al.
  Опубликовано: (2011)
• IL28B-Genotype Testing Now and in the Era of Direct-Acting Antiviral Agents
  по: Morgan, Timothy R., et al.
  Опубликовано: (2010)
• The Role of IL28B Genotype Testing in the Era of Direct Acting Antiviral Agents
  по: Osinusi, Anu, et al.
  Опубликовано: (2012)
• Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling
  по: Dahari, Harel, et al.
  Опубликовано: (2012)
• Emerging Therapies in Hepatitis C: Dawn of the Era of the Direct-Acting Antivirals
  по: Jazwinski, Alison B., et al.
  Опубликовано: (2011)